[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:methyl-cpg-binding-protein-2-duplication-syndrome":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Methyl CpG Binding Protein 2 Duplication Syndrome",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06430385","ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)",[11],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:26.640202Z","2026-05-05T02:35:31.869425Z",[],[]]